STNX yields 2000000.00% · JNJ yields 2.13%● Live data
📍 STNX pulled ahead of the other in Year 1
Combined, STNX + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of STNX + JNJ for your $10,000?
StarTronix International, Inc. develops an integrated computing and communications hardware and software platform for the home PC and the small office home office (SOHO) marketplace. Its StarScreen System is an Internet platform that is used by the company's direct marketing Internet resellers and their customers to provide one-button push access to the Internet for the user. It integrates a desktop computer and either fixed or wireless telephones and intelligent handsets into a complete computing and communications solution for the home PC and small business user. This system features a preorganized Internet menu system enabling on-line banking, bill paying, e-mail, home shopping, video conferencing, and other value added services. The company was formed and incorporated in Delaware as a wholly owned subsidiary of Gold Express Communications, Inc. in August 1995 and later the company absorbed Gold Express in September 1995. StarTronix was previously engaged in the mining and natural resources business. The company has its principal executive offices in Irvine, California.
Full STNX Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.